Gain Therapeutics (GANX)'s 30-day implied volatility (IV30) was 69.8% at the close on November 4, 2026, down from 89.9% the day before, against a 52-week range of 52.6% to 190.4%. Its 20-day historical volatility was 89.6%.
Data as of November 4, 2026.